A Closer Look at Gilenya – The First Oral Treatment for MS

MSAA’s Chief Medical Officer Dr. Jack Burks answers 6 important questions about Gilenya, the new oral medication for MS, including:

  • what is Gilenya
  • how it differs from current FDA-approved disease modifying therapies?
  • side effects
  • who might be a candidate to take it
  • pregnancy issues